YUFLYMA

Celltrion Inc🇨🇦 Health Canada

Approval Id: a7b228d32281d83a
Drug Approval Canada Name: YUFLYMA
Product Name: YUFLYMA
Status: Marketed
Status Date: 2024-06-21
Original Market Date: 2023-08-14
Din: 02535076
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:24.16.92
Atc Original: L04AB04 ADALIMUMAB
Atc Name: l 04 ab 04
Aig Number: 0150364002
Company Name: Celltrion Inc
Company Address: 23 Academy-Ro, Yeonsu-Gu, Incheon, --, Korea, Republic Of, 22014
Company Detail Path: /organization/celltrion-inc

ADALIMUMAB

80 MG / 0.8 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

a7b228d32281d83a

Type

Standard